drugset / Trial / NCT04311762
Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer
Phase 1
Active not recruiting
16 enrolled
University of Vermont
University of Vermont Medical Center · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of the study is to identify the maximum tolerated dose of endobronchial ultrasound-guided transbronchial injection (EBUS-TBNI) of cisplatin for Stage IV lung cancer.
Timeline
- Start
- 2020-02-01
- Primary completion
- 2029-03-01
- Completion
- 2029-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | Other |